Evidence map›Paper›PMID 30874613›Full record

ArticleScientific reports2019

Author Correction: An integrated multi-omics analysis of the NK603 Roundup-tolerant GM maize reveals metabolism disturbances caused by the transformation process.

Robin Mesnage, Sarah Z Agapito-Tenfen, Vinicius Vilperte, George Renney, Malcolm Ward, Gilles-Eric Séralini, Rubens O Nodari, Michael N Antoniou

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Robin MesnageGene Expression and Therapy Group, King's College London, Faculty of Life Sciences & Medicine, Department of Medical and Molecular Genetics, 8th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, United Kingdom.
Sarah Z Agapito-TenfenGenøk, Center for Biosafety, The Science Park, P.O. Box 6418, Tromsø, 9294, Norway.
Vinicius VilperteCropScience Department, Federal University of Santa Catarina, Rod. Admar Gonzaga 1346, 88034-000, Florianópolis, Brazil.
George RenneyProteomics Facility, King's College London, Institute of Psychiatry, London, SE5 8AF, United Kingdom.
Malcolm WardProteomics Facility, King's College London, Institute of Psychiatry, London, SE5 8AF, United Kingdom.
Gilles-Eric SéraliniUniversity of Caen, Institute of Biology, EA 2608 and Network on Risks, Quality and Sustainable Environment, MRSH, Esplanade de la Paix, University of Caen, Caen, 14032, Cedex, France.
Rubens O NodariCropScience Department, Federal University of Santa Catarina, Rod. Admar Gonzaga 1346, 88034-000, Florianópolis, Brazil.
Michael N AntoniouGene Expression and Therapy Group, King's College London, Faculty of Life Sciences & Medicine, Department of Medical and Molecular Genetics, 8th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, United Kingdom. michael.antoniou@kcl.ac.uk.
King's College London · GBUniversidade Federal de Santa Catarina · BRCell Therapy Catapult · GBGenØk · NOUniversité de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Identifiers

PMID30874613
PMCPMC6420507
OpenAlexW2921323796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.